Category: Latest News
-
Fury pulls out of Klitschko rematch through injury
BERLIN (Reuters) – The world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko on Oct. 29 has been called off for a second time with the Briton ruled “medically unfit”. “Tyson has this week been declared medically unfit to fight,” Fury's promoters Hennessy Sports said in a brief statement on Friday. “Medical…
-
Fury pulls out of Klitschko rematch through injury
BERLIN (Reuters) – The world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko on Oct. 29 has been called off for a second time with the Briton ruled “medically unfit”. “Tyson has this week been declared medically unfit to fight,” Fury's promoters Hennessy Sports said in a brief statement on Friday. “Medical…
-
Boxing-‘Medically unfit’ Fury out of Klitschko rematch
* Heavyweight fight called off for second time * Champion Fury’s condition is “too severe” (Adds quotes, details) BERLIN, Sept 23 (Reuters) – Next month’s world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko was called off on Friday for a second time with the Briton ruled “medically unfit”. The fight was…
-
Boxing-‘Medically unfit’ Fury out of Klitschko rematch
* Heavyweight fight called off for second time * Champion Fury’s condition is “too severe” (Adds quotes, details) BERLIN, Sept 23 (Reuters) – Next month’s world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko was called off on Friday for a second time with the Briton ruled “medically unfit”. The fight was…
-
FDA approves Amgen’s copy of AbbVie arthritis drug Humira
The U.S. Food and Drug Administration on Friday approved Amgen Inc’s biosimilar version of AbbVie’s top-selling arthritis drug, Humira. The drug, Amjevita, known also as adalimumab-atto, was approved to treat rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and other conditions. Amjevita is the fourth biosimilar to be approved by the FDA and is expected to…
-
FDA approves Amgen’s copy of AbbVie arthritis drug Humira
The U.S. Food and Drug Administration on Friday approved Amgen Inc’s biosimilar version of AbbVie’s top-selling arthritis drug, Humira. The drug, Amjevita, known also as adalimumab-atto, was approved to treat rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and other conditions. Amjevita is the fourth biosimilar to be approved by the FDA and is expected to…
-
Boxing-Fury pulls out of Klitschko rematch through injury
BERLIN, Sept 23 (Reuters) – The world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko on Oct. 29 has been called off for a second time with the Briton ruled “medically unfit”. “Tyson has this week been declared medically unfit to fight,” Fury’s promoters Hennessy Sports said in a brief statement on…
-
Boxing-Fury pulls out of Klitschko rematch through injury
BERLIN, Sept 23 (Reuters) – The world heavyweight title rematch between champion Tyson Fury and Ukrainian Vladimir Klitschko on Oct. 29 has been called off for a second time with the Briton ruled “medically unfit”. “Tyson has this week been declared medically unfit to fight,” Fury’s promoters Hennessy Sports said in a brief statement on…
-
Cost hampers drive to double number of children treated for starvation: hunger experts
By Alex Whiting ROME (Thomson Reuters Foundation) – A drive to give six million severely malnourished children life-saving treatment every year by 2020 – twice the current number – will only succeed if governments prioritize it alongside other killers and treatment costs are cut, hunger experts said on Thursday. The number of children treated for severe…
-
U.N. resumes Syria aid delivery after attack
By Stephanie Nebehay and Tom Miles GENEVA (Reuters) – The United Nations appealed to Syrian President Bashar al-Assad and rebel groups on Thursday to allow aid convoys to enter eastern Aleppo as U.N. relief operations in Syria resumed after a 48-hour suspension due to a deadly attack. A U.N. convoy loaded with medical and other…